PGP and neoplasm: In addition to P-gp+ MDR tumor cell populations, c-erbB2(+) positive breast cancer cells may be eradicated to a better extent with c-erbB2 mAb + LAK cells since LAK cells have strong antibody-dependent cell-mediated cytotoxic (ADCC) activity [16].